Medical Supply Platform Zoplar Nets $3.4 Mn Led By Blume Ventures

B2B medical supply platform Zoplar has secured $3.4 Mn (around INR 29.14 Cr) as part of its Series A funding round led by Blume Ventures. The round also saw participation from BEENEXT, Saison Capital, Atrium Angels, Finfirst and LogX Ventures.

The fresh funds will be utilised to bolster its operational capabilities by focussing on backward integration in the supply chain and developing a robust service engineering team, the startup said in a statement.

“This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies. It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care,” Zoplar cofounders Amit Sah and Umesh Sharma said in a joint statement.

Commenting on the fundraise, lead investor at Blume Ventures, Sajith Pai, added, “We invested in Zoplar because we believe in their vision and the potential impact they can have on the healthcare landscape in India. Their commitment to improving the procurement and after-sales service in medical equipment is commendable and aligns with our focus on supporting ventures that drive meaningful societal change”.

Founded in 2022 by Sah and Sharma, Zoplar is a medical equipment procurement platform for small and medium-sized hospitals in India. The startup claims to be a one stop platform for hospital requirements and aims to make medical supply procurement more convenient and cost-effective for its clients.

Including the current round, the Delhi NCR-based startup has raised $5.1 Mn in total funding till date. It is also backed by the likes of Titan Capital, Stride Ventures and Panthera Peak.

It competes with the likes of Medikabazaar, PharmEasy-owned Aknamed, Saveo, among others.

Zoplar operates in the larger Indian healthtech space, which saw healthy interest from investors in 2024. As per Inc42 data, healthtech was the sixth most funded sector last year as it raised $716 Mn across 78 deals.

Meanwhile, it is pertinent to note that the reports estimate the Indian hospital supplies market to become a $1.78 Bn opportunity by 2030.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.